Mayne Pharma Group Share Price and Company Fundamentals
Last traded: Today at 3:44 AM
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.
Key Metrics
PE ratio
-
PB ratio
0.60
Dividend yield
-
Beta
1.06
Market cap
$221.80M
Enterprise value
$159.42M
Company profile
| Industry / Sector | Medical Distribution / Healthcare |
|---|---|
| Full time employees | 491 |
| Website | https://www.maynepharma.com |
| Mailing address | 1538 Main North Road Salisbury South SA 5106 Australia |
| Phone / Fax | 61 8 8209 2666 / 61 8 8281 0284 |
Dividends
More: Mayne Pharma Group Dividend history, yield and payout ratio
Dividend yield
-
Dividend amount
$-
Payout ratio
0.00%
5Y Avg. yield
-%
Mayne Pharma Group paid $- dividend and the ex-dividend date was 18 Jan 2023.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MYX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Mayne Pharma Group.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Shawn Patrick O'Brien M.B.A., M.S. | CEO, MD & Director | 66 | |
| Mr. Aaron Gray | Chief Financial Officer | ||
| Dr. Thomas Duthy M.B.A., Ph.D. | Manager of Investor Relations | ||
| Ms. Kimberly Parker J.D. | Executive VP & General Counsel | ||
| Mr. Brant Schofield | Executive Vice President of Corporate Development | 59 | |
| Mr. Kurt Reyes | Interim Global Head of People | ||
| Mr. Daniel Moore | Executive Vice President of Specialty Products & Patient Solutions | ||
| Dr. Frank Casty M.D. | Executive VP, Global Head of R&D and Chief Medical Officer | ||
| Mr. Tony Ramy | Executive Vice President of Women's Health | ||
| Mr. Brenton Walter | Financial Controller |
Profitability and management effectiveness
Profit margin
-22.99%
Operating margin
-8.54%
Return on assets
-1.28%
Return on equity
-21.85%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Mayne Pharma Group is 221.80M and its enterprise value is 159.42M. The enterprise value to revenue ratio of MYX is 0.39. The enterprise value to EBITDA ratio of MYX is 3.79.
The MYX's stocks Beta value is 1.06 making it 6% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Mayne Pharma Group (MYX)
Mayne Pharma Group (ASX:MYX) Frequently Asked Questions
1. What is Mayne Pharma Group's Stock Symbol?
Mayne Pharma Group trades on ASX under the ticker symbol "MYX".
2. What is Mayne Pharma Group's stock price today?
One share of MYX stock can currently be purchased for approximately $2.73.
3. How can I contact Mayne Pharma Group?
Mayne Pharma Group's mailing address is 1538 Main North Road Salisbury South SA 5106 Australia. The company can be reached via phone at 61 8 8209 2666.
4. What is Mayne Pharma Group's official website?
The official website of Mayne Pharma Group is https://www.maynepharma.com.